CDCA8 anticorps (N-Term)
Aperçu rapide pour CDCA8 anticorps (N-Term) (ABIN2230246)
Antigène
Voir toutes CDCA8 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 16-46, N-Term
-
Réactivité croisée
- Humain
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu
-
Attributs du produit
- CDCA8, NT (CDCA8, PESCRG3, Borealin, Dasra-B, Cell division cycle-associated protein 8, Pluripotent embryonic stem cell-related gene 3 protein)
-
Purification
- Purified by saturated ammonium sulfate precipitation followed by dialysis against PBS.
-
Immunogène
- CDCA8 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 16-46 amino acids from the N-terminal region of human CDCA8.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- CDCA8 (Cell Division Cycle Associated 8 (CDCA8))
-
Autre désignation
- CDCA8
-
NCBI Accession
- NP_060571
-
UniProt
- Q53HL2
-
Pathways
- Cycle Cellulaire, M Phase
Antigène
-